Glycan analysis of therapeutic glycoproteins

References

• Jefferis R. Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action. Trends Pharmacol Sci 2009; 30:356–62; PMID:19552968; http://dx.doi.org/10.1016/j.tips.2009.04.007
   PubMed Web of Science ®Google Scholar
• Sola RJ, Griebenow K. Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy. BioDrugs 2010; 24:9–21; PMID:20055529; http://dx.doi.org/10.2165/11530550-000000000-00000
   PubMed Web of Science ®Google Scholar
• Sola RJ, Griebenow K. Effects of glycosylation on the stability of protein pharmaceuticals. J Pharm Sci 2009; 98:1223–45; PMID:18661536; http://dx.doi.org/10.1002/jps.21504
   PubMed Web of Science ®Google Scholar
• Zheng K, Bantog C, Bayer R. The impact of glycosylation on monoclonal antibody conformation and stability. MAbs 2011; 3:568–76; PMID:22123061; http://dx.doi.org/10.4161/mabs.3.6.17922
   PubMed Web of Science ®Google Scholar
• Alsenaidy MA, Okbazghi SZ, Kim JH, Joshi SB, Middaugh CR, Tolbert TJ, Volkin DB. Physical stability comparisons of IgG1-Fc variants: effects of N-glycosylation site occupancy and Asp/Gln residues at site Asn 297. J Pharm Sci 2014; 103:1613–27; PMID:24740840; http://dx.doi.org/10.1002/jps.23975
   PubMed Web of Science ®Google Scholar
• Narhi LO, Arakawa T, Aoki KH, Elmore R, Rohde MF, Boone T, Strickland TW. The effect of carbohydrate on the structure and stability of erythropoietin. J Biol Chem 1991; 266:23022–6; PMID:1744097
   PubMed Web of Science ®Google Scholar
• Desnick RJ, Schuchman EH. Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges. Annu Rev Genomics Hum Genet 2012; 13:307–35; PMID:22970722; http://dx.doi.org/10.1146/annurev-genom-090711-163739
   PubMed Web of Science ®Google Scholar
• Morell AG, Gregoriadis G, Scheinberg IH, Hickman J, Ashwell G. The role of sialic acid in determining the survival of glycoproteins in the circulation. J Biol Chem 1971; 246:1461–7; PMID:5545089
   PubMed Web of Science ®Google Scholar
• Stadlmann J, Pabst M, Altmann F. Analytical and Functional Aspects of Antibody Sialylation. J Clin Immunol 2010; 30 Suppl 1:S15–9; PMID:20390325
   PubMedGoogle Scholar
• Sondermann P, Pincetic A, Maamary J, Lammens K, Ravetch JV. General mechanism for modulating immunoglobulin effector function. Proc Natl Acad Sci U S A 2013; 110:9868–72; PMID:23697368; http://dx.doi.org/10.1073/pnas.1307864110
   PubMed Web of Science ®Google Scholar
• Bohm S, Schwab I, Lux A, Nimmerjahn F. The role of sialic acid as a modulator of the anti-inflammatory activity of IgG. Semin Immunopathol 2012; 34:443–53; PMID:22437760; http://dx.doi.org/10.1007/s00281-012-0308-x
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. Translating basic mechanisms of IgG effector activity into next generation cancer therapies. Cancer Immun 2012; 12:13; PMID:22896758
   PubMedGoogle Scholar
• Reusch D, Tejada ML. Fc glycans of therapeutic antibodies as critical quality attributes. Glycobiology 2015; 25(12):1325–34; PMID:26263923
   PubMed Web of Science ®Google Scholar
• Beck A, Reichert JM. Marketing approval of mogamulizumab: a triumph for glyco-engineering. MAbs 2012; 4:419–25; PMID:22699226; http://dx.doi.org/10.4161/mabs.20996
   PubMed Web of Science ®Google Scholar
• Schachter H. The joys of HexNAc. The synthesis and function of N- and O-glycan branches. Glycoconj J 2000; 17:465–83; PMID:11421343; http://dx.doi.org/10.1023/A:1011010206774
   PubMed Web of Science ®Google Scholar
• Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 1985; 54:631–64; PMID:3896128; http://dx.doi.org/10.1146/annurev.bi.54.070185.003215
   PubMed Web of Science ®Google Scholar
• Ten Hagen KG, Fritz TA, Tabak LA. All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. Glycobiology 2003; 13:1R–16R; PMID:12634319; http://dx.doi.org/10.1093/glycob/cwg007
   Google Scholar
• Hattrup CL, Gendler SJ. Structure and function of the cell surface (tethered) mucins. Annu Rev Physiol 2008; 70:431–57; PMID:17850209; http://dx.doi.org/10.1146/annurev.physiol.70.113006.100659
   PubMed Web of Science ®Google Scholar
• Hossler P, Khattak SF, Li ZJ. Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology 2009; 19:936–49; PMID:19494347; http://dx.doi.org/10.1093/glycob/cwp079
   PubMed Web of Science ®Google Scholar
• Ma JK, Drake PM, Christou P. The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 2003; 4:794–805; PMID:14526375; http://dx.doi.org/10.1038/nrg1177
   PubMed Web of Science ®Google Scholar
• Houdebine LM. Production of pharmaceutical proteins by transgenic animals. Comp Immunol Microbiol Infect Dis 2009; 32:107–21; PMID:18243312; http://dx.doi.org/10.1016/j.cimid.2007.11.005
   PubMed Web of Science ®Google Scholar
• Beck A, Debaene F, Diemer H, Wagner-Rousset E, Colas O, Dorsselaer AV, Cianferani S. Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies. J Mass Spectrom 2015; 50:285–97; PMID:25800010; http://dx.doi.org/10.1002/jms.3554
   PubMed Web of Science ®Google Scholar
• Beck A, Reichert JM. Approval of the first biosimilar antibodies in Europe: a major landmark for the biopharmaceutical industry. MAbs 2013; 5:621–3; PMID:23924791; http://dx.doi.org/10.4161/mabs.25864
   PubMed Web of Science ®Google Scholar
• Beck A, Wagner-Rousset E, Ayoub D, Van DA, Sanglier-Cianferani S. Characterization of therapeutic antibodies and related products. Anal Chem 2013; 85:715–36; PMID:23134362; http://dx.doi.org/10.1021/ac3032355
   PubMed Web of Science ®Google Scholar
• Lingg N, Zhang P, Song Z, Bardor M. The sweet tooth of biopharmaceuticals: importance of recombinant protein glycosylation analysis. Biotechnol J 2012; 7:1462–72; PMID:22829536; http://dx.doi.org/10.1002/biot.201200078
   PubMed Web of Science ®Google Scholar
• Dotz V, Haselberg R, Shubhakar A, Kozak RP, Falck D, Rombouts Y, Reusch D, Somsen GW, Fernandes DL, Wuhrer M. Mass spectrometry for glycosylation analysis of biopharmaceuticals. TrAC Trends Analyt Chem 2015; 73:1–9; http://dx.doi.org/10.1016/j.trac.2015.04.024
   Google Scholar
• Zhang Z, Pan H, Chen X. Mass spectrometry for structural characterization of therapeutic antibodies. Mass Spectrom Rev 2009; 28:147–76; PMID:18720354; http://dx.doi.org/10.1002/mas.20190
   PubMed Web of Science ®Google Scholar
• Xie H, Chakraborty A, Ahn J, Yu YQ, Dakshinamoorthy DP, Gilar M, Chen W, Skilton SJ, Mazzeo JR. Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies. MAbs 2010; 2:379–94; PMID:20458189; http://dx.doi.org/10.4161/mabs.11986
   PubMed Web of Science ®Google Scholar
• Ayoub D, Jabs W, Resemann A, Evers W, Evans C, Main L, Baessmann C, Wagner-Rousset E, Suckau D, Beck A. Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques. MAbs 2013; 5:699–710; PMID:23924801; http://dx.doi.org/10.4161/mabs.25423
   PubMed Web of Science ®Google Scholar
• Xu CF, Zang L, Weiskopf A. Size-exclusion chromatography-mass spectrometry with m-nitrobenzyl alcohol as post-column additive for direct characterization of size variants of monoclonal antibodies. J Chromatogr B Analyt Technol Biomed Life Sci 2014; 960:230–8; PMID:24835510; http://dx.doi.org/10.1016/j.jchromb.2014.04.023
   PubMed Web of Science ®Google Scholar
• Liu H, Gaza-Bulseco G, Chumsae C. Analysis of reduced monoclonal antibodies using size exclusion chromatography coupled with mass spectrometry. J Am Soc Mass Spectrom 2009; 20:2258–64; PMID:19786356; http://dx.doi.org/10.1016/j.jasms.2009.08.015
   PubMed Web of Science ®Google Scholar
• Brady LJ, Valliere-Douglass J, Martinez T, Balland A. Molecular mass analysis of antibodies by on-line SEC-MS. J Am Soc Mass Spectrom 2008; 19:502–9; PMID:18258452; http://dx.doi.org/10.1016/j.jasms.2007.12.006
   PubMed Web of Science ®Google Scholar
• Harazono A, Hashii N, Kuribayashi R, Nakazawa S, Kawasaki N. Mass spectrometric glycoform profiling of the innovator and biosimilar erythropoietin and darbepoetin by LC/ESI-MS. J Pharm Biomed Anal 2013; 83:65–74; PMID:23708432; http://dx.doi.org/10.1016/j.jpba.2013.04.031
   PubMed Web of Science ®Google Scholar
• Rosati S, Rose RJ, Thompson NJ, vanGÇàDuijn E, Damoc E, Denisov E, Makarov A, Heck AJR. Exploring an Orbitrap Analyzer for the Characterization of Intact Antibodies by Native Mass Spectrometry. Angewandte Chemie International Edition 2012; 51:12992–6; http://dx.doi.org/10.1002/anie.201206745
   PubMed Web of Science ®Google Scholar
• Rosati S, van den Bremer ET, Schuurman J, Parren PW, Kamerling JP, Heck AJ. In-depth qualitative and quantitative analysis of composite glycosylation profiles and other micro-heterogeneity on intact monoclonal antibodies by high-resolution native mass spectrometry using a modified Orbitrap. MAbs 2013; 5:917–24; PMID:23995615; http://dx.doi.org/10.4161/mabs.26282
   PubMed Web of Science ®Google Scholar
• Thompson NJ, Rosati S, Rose RJ, Heck AJ. The impact of mass spectrometry on the study of intact antibodies: from post-translational modifications to structural analysis. Chem Commun (Camb) 2013; 49:538–48; PMID:23183499; http://dx.doi.org/10.1039/C2CC36755F
   PubMed Web of Science ®Google Scholar
• Jung SK, Lee KH, Jeon JW, Lee JW, Kwon BO, Kim YJ, Bae JS, Kim DI, Lee SY, Chang SJ. Physicochemical characterization of Remsima. MAbs 2014; 6:1163–77; PMID:25517302; http://dx.doi.org/10.4161/mabs.32221
   PubMed Web of Science ®Google Scholar
• Crivianu-Gaita V, Romaschin A, Thompson M. High efficiency reduction capability for the formation of Fab׳ antibody fragments from F(ab)2 units. Biochem Biophysics Rep 2015; 2:23–8; http://dx.doi.org/10.1016/j.bbrep.2015.04.004
   Google Scholar
• Brezski RJ, Jordan RE. Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity? MAbs 2010; 2:212–20; PMID:20400859; http://dx.doi.org/10.4161/mabs.2.3.11780
   PubMed Web of Science ®Google Scholar
• Janin-Bussat MC, Tonini L, Huillet C, Colas O, Klinguer-Hamour C, Corvaia N, Beck A. Cetuximab Fab and Fc N-glycan fast characterization using IdeS digestion and liquid chromatography coupled to electrospray ionization mass spectrometry. Methods Mol Biol 2013; 988:93–113; PMID:23475716; http://dx.doi.org/10.1007/978-1-62703-327-5_7
   PubMedGoogle Scholar
• Zhao SS, Chen DD. Applications of capillary electrophoresis in characterizing recombinant protein therapeutics. Electrophoresis 2014; 35:96–108; PMID:24123141; http://dx.doi.org/10.1002/elps.201300372
   PubMed Web of Science ®Google Scholar
• Haselberg R, de Jong GJ, Somsen GW. Low-flow sheathless capillary electrophoresis-mass spectrometry for sensitive glycoform profiling of intact pharmaceutical proteins. Anal Chem 2013; 85:2289–96; PMID:23323765; http://dx.doi.org/10.1021/ac303158f
   PubMed Web of Science ®Google Scholar
• Thakur D, Rejtar T, Karger BL, Washburn NJ, Bosques CJ, Gunay NS, Shriver Z, Venkataraman G. Profiling the glycoforms of the intact α subunit of recombinant human chorionic gonadotropin by high-resolution capillary electrophoresis-mass spectrometry. Anal Chem 2009; 81:8900–7; PMID:19817480; http://dx.doi.org/10.1021/ac901506p
   PubMed Web of Science ®Google Scholar
• Reichel C, Thevis M. Gel electrophoretic methods for the analysis of biosimilar pharmaceuticals using the example of recombinant erythropoietin. Bioanalysis 2013; 5:587–602; PMID:23425274; http://dx.doi.org/10.4155/bio.13.9
   PubMed Web of Science ®Google Scholar
• de Kort BJ, de Jong GJ, Somsen GW. Profiling of erythropoietin products by capillary electrophoresis with native fluorescence detection. Electrophoresis 2012; 33:2996–3001; PMID:23002011; http://dx.doi.org/10.1002/elps.201200303
   PubMed Web of Science ®Google Scholar
• Suba D, Urbanyi Z, Salgo A. Capillary isoelectric focusing method development and validation for investigation of recombinant therapeutic monoclonal antibody. J Pharm Biomed Anal 2015; 114:53–61; PMID:26025812; http://dx.doi.org/10.1016/j.jpba.2015.04.037
   PubMed Web of Science ®Google Scholar
• Schiestl M, Stangler T, Torella C, Cepeljnik T, Toll H, Grau R. Acceptable changes in quality attributes of glycosylated biopharmaceuticals. Nat Biotechnol 2011; 29:310–2; PMID:21478841; http://dx.doi.org/10.1038/nbt.1839
   PubMed Web of Science ®Google Scholar
• Federici M, Lubiniecki A, Manikwar P, Volkin DB. Analytical lessons learned from selected therapeutic protein drug comparability studies. Biologicals 2013; 41:131–47; PMID:23146362; http://dx.doi.org/10.1016/j.biologicals.2012.10.001
   PubMed Web of Science ®Google Scholar
• Staub A, Guillarme D, Schappler J, Veuthey JL, Rudaz S. Intact protein analysis in the biopharmaceutical field. J Pharm Biomed Anal 2011; 55:810–22; PMID:21334842; http://dx.doi.org/10.1016/j.jpba.2011.01.031
   PubMed Web of Science ®Google Scholar
• Bongers J, Devincentis J, Fu J, Huang P, Kirkley DH, Leister K, Liu P, Ludwig R, Rumney K, Tao L, et al. Characterization of glycosylation sites for a recombinant IgG1 monoclonal antibody and a CTLA4-Ig fusion protein by liquid chromatography-mass spectrometry peptide mapping. J Chromatogr A 2011; 1218:8140–9; PMID:21978954; http://dx.doi.org/10.1016/j.chroma.2011.08.089
   PubMed Web of Science ®Google Scholar
• Gong B, Cukan M, Fisher R, Li H, Stadheim TA, Gerngross T. Characterization of N-linked glycosylation on recombinant glycoproteins produced in Pichia pastoris using ESI-MS and MALDI-TOF. Methods Mol Biol 2009; 534:213–23; PMID:19277549
   PubMedGoogle Scholar
• Huang LJ, Lin JH, Tsai JH, Chu YY, Chen YW, Chen SL, Chen SH. Identification of protein O-glycosylation site and corresponding glycans using liquid chromatography-tandem mass spectrometry via mapping accurate mass and retention time shift. J Chromatogr A 2014; 1371:136–45; PMID:25456591; http://dx.doi.org/10.1016/j.chroma.2014.10.046
   PubMed Web of Science ®Google Scholar
• Houel S, Hilliard M, Yu YQ, McLoughlin N, Martin SM, Rudd PM, Williams JP, Chen W. N- and O-glycosylation analysis of etanercept using liquid chromatography and quadrupole time-of-flight mass spectrometry equipped with electron-transfer dissociation functionality. Anal Chem 2014; 86:576–84; PMID:24308717; http://dx.doi.org/10.1021/ac402726h
   PubMed Web of Science ®Google Scholar
• Kolarich D, Jensen PH, Altmann F, Packer NH. Determination of site-specific glycan heterogeneity on glycoproteins. Nat Protoc 2012; 7:1285–98; PMID:22678432; http://dx.doi.org/10.1038/nprot.2012.062
   PubMed Web of Science ®Google Scholar
• Ongay S, Boichenko A, Govorukhina N, Bischoff R. Glycopeptide enrichment and separation for protein glycosylation analysis. J Sep Sci 2012; 35:2341–72; PMID:22997027; http://dx.doi.org/10.1002/jssc.201200434
   PubMed Web of Science ®Google Scholar
• Desaire H. Glycopeptide analysis, recent developments and applications. Mol Cell Proteomics 2013; 12:893–901; PMID:23389047; http://dx.doi.org/10.1074/mcp.R112.026567
   PubMed Web of Science ®Google Scholar
• Hua S, Nwosu CC, Strum JS, Seipert RR, An HJ, Zivkovic AM, German JB, Lebrilla CB. Site-specific protein glycosylation analysis with glycan isomer differentiation. Anal Bioanal Chem 2012; 403:1291–302; PMID:21647803; http://dx.doi.org/10.1007/s00216-011-5109-x
   PubMed Web of Science ®Google Scholar
• Reusch D, Haberger M, Selman MH, Bulau P, Deelder AM, Wuhrer M, Engler N. High-throughput work flow for IgG Fc-glycosylation analysis of biotechnological samples. Anal Biochem 2013; 432:82–9; PMID:23026777; http://dx.doi.org/10.1016/j.ab.2012.09.032
   PubMed Web of Science ®Google Scholar
• Harrison R, Hitchen PG, Panico M, Morris HR, Mekhaiel D, Pleass RJ, Dell A, Hewitt JE, Haslam SM. Glycoproteomic characterization of recombinant mouse α-dystroglycan. Glycobiology 2012; 22:662–75; PMID:22241827; http://dx.doi.org/10.1093/glycob/cws002
   PubMed Web of Science ®Google Scholar
• Reusch D, Haberger M, Falck D, Peter B, Maier B, Gassner J, Hook M, Wagner K, Bonnington L, Bulau P, et al. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods. MAbs 2015; 7:732–42; PMID:25996192; http://dx.doi.org/10.1080/19420862.2015.1045173
   PubMed Web of Science ®Google Scholar
• Scott NE, Parker BL, Connolly AM, Paulech J, Edwards AV, Crossett B, Falconer L, Kolarich D, Djordjevic SP, Hojrup P, et al. Simultaneous glycan-peptide characterization using hydrophilic interaction chromatography and parallel fragmentation by CID, higher energy collisional dissociation, and electron transfer dissociation MS applied to the N-linked glycoproteome of Campylobacter jejuni. Mol Cell Proteomics 2011; 10:M000031-MMCP201; PMID:20360033; http://dx.doi.org/10.1074/mcp.M000031-MCP201
   Web of Science ®Google Scholar
• Jiang H, Wu SL, Karger BL, Hancock WS. Characterization of the glycosylation occupancy and the active site in the follow-on protein therapeutic: TNK-tissue plasminogen activator. Anal Chem 2010; 82:6154–62; PMID:20552988; http://dx.doi.org/10.1021/ac100956x
   PubMed Web of Science ®Google Scholar
• Gahoual R, Burr A, Busnel JM, Kuhn L, Hammann P, Beck A, Francois YN, Leize-Wagner E. Rapid and multi-level characterization of trastuzumab using sheathless capillary electrophoresis-tandem mass spectrometry. MAbs 2013; 5:479–90; PMID:23563524; http://dx.doi.org/10.4161/mabs.23995
   PubMed Web of Science ®Google Scholar
• Whitmore CD, Gennaro LA. Capillary electrophoresis-mass spectrometry methods for tryptic peptide mapping of therapeutic antibodies. Electrophoresis 2012; 33:1550–6; PMID:22736356; http://dx.doi.org/10.1002/elps.201200066
   PubMed Web of Science ®Google Scholar
• Wada Y, Dell A, Haslam SM, Tissot B, Canis K, Azadi P, Backstrom M, Costello CE, Hansson GC, Hiki Y, et al. Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1. Mol Cell Proteomics 2010; 9:719–27; PMID:20038609; http://dx.doi.org/10.1074/mcp.M900450-MCP200
   PubMed Web of Science ®Google Scholar
• Sanchez-De Melo I, Grassi P, Ochoa F, Bolivar J, Garcia-Cozar FJ, Duran-Ruiz MC. N-glycosylation profile analysis of Trastuzumab biosimilar candidates by Normal Phase Liquid Chromatography and MALDI-TOF MS approaches. J Proteomics 2015; 127:225–33; PMID:25907685; http://dx.doi.org/10.1016/j.jprot.2015.04.012
   PubMed Web of Science ®Google Scholar
• Marino K, Bones J, Kattla JJ, Rudd PM. A systematic approach to protein glycosylation analysis: a path through the maze. Nat Chem Biol 2010; 6:713–23; PMID:20852609; http://dx.doi.org/10.1038/nchembio.437
   PubMed Web of Science ®Google Scholar
• Reiding KR, Blank D, Kuijper DM, Deelder AM, Wuhrer M. High-throughput profiling of protein N-glycosylation by MALDI-TOF-MS employing linkage-specific sialic acid esterification. Anal Chem 2014; 86:5784–93; PMID:24831253; http://dx.doi.org/10.1021/ac500335t
   PubMed Web of Science ®Google Scholar
• Ruhaak LR, Zauner G, Huhn C, Bruggink C, Deelder AM, Wuhrer M. Glycan labeling strategies and their use in identification and quantification. Anal Bioanal Chem 2010; 397:3457–81; PMID:20225063; http://dx.doi.org/10.1007/s00216-010-3532-z
   PubMed Web of Science ®Google Scholar
• Kozak RP, Tortosa CB, Fernandes DL, Spencer DI. Comparison of procainamide and 2-aminobenzamide labeling for profiling and identification of glycans by liquid chromatography with fluorescence detection coupled to electrospray ionization-mass spectrometry. Anal Biochem 2015; 486:38–40; PMID:26079702; http://dx.doi.org/10.1016/j.ab.2015.06.006
   PubMed Web of Science ®Google Scholar
• Melmer M, Stangler T, Schiefermeier M, Brunner W, Toll H, Rupprechter A, Lindner W, Premstaller A. HILIC analysis of fluorescence-labeled N-glycans from recombinant biopharmaceuticals. Anal Bioanal Chem 2010; 398:905–14; PMID:20640408; http://dx.doi.org/10.1007/s00216-010-3988-x
   PubMed Web of Science ®Google Scholar
• Shang TQ, Saati A, Toler KN, Mo J, Li H, Matlosz T, Lin X, Schenk J, Ng CK, Duffy T, et al. Development and application of a robust N-glycan profiling method for heightened characterization of monoclonal antibodies and related glycoproteins. J Pharm Sci 2014; 103:1967–78; PMID:24840237; http://dx.doi.org/10.1002/jps.24004
   PubMed Web of Science ®Google Scholar
• Melmer M, Stangler T, Premstaller A, Lindner W. Comparison of hydrophilic-interaction, reversed-phase and porous graphitic carbon chromatography for glycan analysis. J Chromatogr A 2011; 1218:118–23; PMID:21122866; http://dx.doi.org/10.1016/j.chroma.2010.10.122
   PubMed Web of Science ®Google Scholar
• Pabst M, Altmann F. Glycan analysis by modern instrumental methods. Proteomics 2011; 11:631–43; PMID:21241022; http://dx.doi.org/10.1002/pmic.201000517
   PubMed Web of Science ®Google Scholar
• Royle L, Dwek RA, Rudd PM. Determining the structure of oligosaccharides N- and O-linked to glycoproteins. Curr Protoc Protein Sci 2006; 12:12.6.1-12.6.45; Chapter 12:Unit; PMID:18429295
   PubMedGoogle Scholar
• Grey C, Edebrink P, Krook M, Jacobsson SP. Development of a high performance anion exchange chromatography analysis for mapping of oligosaccharides. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877:1827–32; PMID:19482525; http://dx.doi.org/10.1016/j.jchromb.2009.05.003
   PubMed Web of Science ®Google Scholar
• Guttman A. High-resolution carbohydrate profiling by capillary gel electrophoresis. Nature 1996; 380:461–2; PMID:8602248; http://dx.doi.org/10.1038/380461a0
   PubMed Web of Science ®Google Scholar
• Guttman A, Chen FT, Evangelista RA. Separation of 1-aminopyrene-3,6,8-trisulfonate-labeled asparagine-linked fetuin glycans by capillary gel electrophoresis. Electrophoresis 1996; 17:412–7; PMID:8900952; http://dx.doi.org/10.1002/elps.1150170221
   PubMed Web of Science ®Google Scholar
• Kamoda S, Ishikawa R, Kakehi K. Capillary electrophoresis with laser-induced fluorescence detection for detailed studies on N-linked oligosaccharide profile of therapeutic recombinant monoclonal antibodies. J Chromatogr A 2006; 1133:332–9; PMID:16945378; http://dx.doi.org/10.1016/j.chroma.2006.08.028
   PubMed Web of Science ®Google Scholar
• Mechref Y, Muzikar J, Novotny MV. Comprehensive assessment of N-glycans derived from a murine monoclonal antibody: a case for multimethodological approach. Electrophoresis 2005; 26:2034–46; PMID:15841499; http://dx.doi.org/10.1002/elps.200410345
   PubMed Web of Science ®Google Scholar
• Ma S, Nashabeh W. Carbohydrate analysis of a chimeric recombinant monoclonal antibody by capillary electrophoresis with laser-induced fluorescence detection. Anal Chem 1999; 71:5185–92; PMID:10575965; http://dx.doi.org/10.1021/ac990376z
   PubMed Web of Science ®Google Scholar
• Callewaert N, Van VH, Van HA, Laroy W, Delanghe J, Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med 2004; 10:429–34; PMID:15152612; http://dx.doi.org/10.1038/nm1006
   PubMed Web of Science ®Google Scholar
• Gennaro LA, Salas-Solano O, Ma S. Capillary electrophoresis-mass spectrometry as a characterization tool for therapeutic proteins. Anal Biochem 2006; 355:249–58; PMID:16712766; http://dx.doi.org/10.1016/j.ab.2006.04.002
   PubMed Web of Science ®Google Scholar
• Balaguer E, Demelbauer U, Pelzing M, Sanz-Nebot V, Barbosa J, Neususs C. Glycoform characterization of erythropoietin combining glycan and intact protein analysis by capillary electrophoresis - electrospray - time-of-flight mass spectrometry. Electrophoresis 2006; 27:2638–50; PMID:16817164; http://dx.doi.org/10.1002/elps.200600075
   PubMed Web of Science ®Google Scholar
• Taichrib A, Pioch M, Neususs C. Multivariate statistics for the differentiation of erythropoietin preparations based on intact glycoforms determined by CE-MS. Anal Bioanal Chem 2012; 403:797–805; PMID:22430131; http://dx.doi.org/10.1007/s00216-012-5924-8
   PubMed Web of Science ®Google Scholar
• Gennaro LA, Salas-Solano O. On-line CE-LIF-MS technology for the direct characterization of N-linked glycans from therapeutic antibodies. Anal Chem 2008; 80:3838–45; PMID:18426228http://dx.doi.org/10.1021/ac800152h
   PubMed Web of Science ®Google Scholar
• Balaguer E, Neususs C. Glycoprotein characterization combining intact protein and glycan analysis by capillary electrophoresis-electrospray ionization-mass spectrometry. Anal Chem 2006; 78:5384–93; PMID:16878873; http://dx.doi.org/; http://dx.doi.org/10.1021/ac060376g
   Google Scholar
• Reusch D, Haberger M, Maier B, Maier M, Kloseck R, Zimmermann B, Hook M, Szabo Z, Tep S, Wegstein J, et al. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles–part 1: separation-based methods. MAbs 2015; 7:167–79; PMID:25524468; http://dx.doi.org/10.4161/19420862.2014.986000
   PubMed Web of Science ®Google Scholar
• Qian J, Liu T, Yang L, Daus A, Crowley R, Zhou Q. Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion. Anal Biochem 2007; 364:8–18; PMID:17362871; http://dx.doi.org/10.1016/j.ab.2007.01.023
   PubMed Web of Science ®Google Scholar
• Jensen PH, Karlsson NG, Kolarich D, Packer NH. Structural analysis of N- and O-glycans released from glycoproteins. Nat Protoc 2012; 7:1299–310; PMID:22678433; http://dx.doi.org/10.1038/nprot.2012.063
   PubMed Web of Science ®Google Scholar
• Harvey DJ. Fragmentation of negative ions from carbohydrates: part 1. Use of nitrate and other anionic adducts for the production of negative ion electrospray spectra from N-linked carbohydrates. J Am Soc Mass Spectrom 2005; 16:622–30; PMID:15862764; http://dx.doi.org/10.1016/j.jasms.2005.01.004
   PubMed Web of Science ®Google Scholar
• Harvey DJ. Fragmentation of negative ions from carbohydrates: part 2. Fragmentation of high-mannose N-linked glycans. J Am Soc Mass Spectrom 2005; 16:631–46; PMID:15862765; http://dx.doi.org/10.1016/j.jasms.2005.01.005
   PubMed Web of Science ®Google Scholar
• Harvey DJ. Fragmentation of negative ions from carbohydrates: part 3. Fragmentation of hybrid and complex N-linked glycans. J Am Soc Mass Spectrom 2005; 16:647–59; PMID:15862766; http://dx.doi.org/10.1016/j.jasms.2005.01.006
   PubMed Web of Science ®Google Scholar
• Wormald MR, Petrescu AJ, Pao YL, Glithero A, Elliott T, Dwek RA. Conformational studies of oligosaccharides and glycopeptides: complementarity of NMR, X-ray crystallography, and molecular modelling. Chem Rev 2002; 102:371–86; PMID:11841247; http://dx.doi.org/10.1021/cr990368i
   PubMed Web of Science ®Google Scholar
• Halbeek H. Structural Characterization of the Carbohydrate Moieties of Glycoproteins by High-Resolution (1)H-NMR Spectroscopy. Methods Mol Biol 1993; 17:115–48; PMID:21400136
   PubMedGoogle Scholar
• Yamaguchi Y, Nishima W, Re S, Sugita Y. Confident identification of isomeric N-glycan structures by combined ion mobility mass spectrometry and hydrophilic interaction liquid chromatography. Rapid Commun Mass Spectrom 2012; 26:2877–84; PMID:23136018; http://dx.doi.org/10.1002/rcm.6412
   PubMed Web of Science ®Google Scholar
• Tangvoranuntakul P, Gagneux P, Diaz S, Bardor M, Varki N, Varki A, Muchmore E. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci U S A 2003; 100:12045–50; PMID:14523234; http://dx.doi.org/10.1073/pnas.2131556100
   PubMed Web of Science ®Google Scholar
• Orvisky E, Stubblefield B, Long RT, Martin BM, Sidransky E, Krasnewich D. Phosphomannomutase activity in congenital disorders of glycosylation type Ia determined by direct analysis of the interconversion of mannose-1-phosphate to mannose-6-phosphate by high-pH anion-exchange chromatography with pulsed amperometric detection. Anal Biochem 2003; 317:12–8; PMID:12729595; http://dx.doi.org/10.1016/S0003-2697(03)00109-X
   PubMed Web of Science ®Google Scholar
• Keck R, Nayak N, Lerner L, Raju S, Ma S, Schreitmueller T, Chamow S, Moorhouse K, Kotts C, Jones A. Characterization of a complex glycoprotein whose variable metabolic clearance in humans is dependent oN-terminal N-acetylglucosamine content. Biologicals 2008; 36:49–60; PMID:17728143; http://dx.doi.org/10.1016/j.biologicals.2007.05.004
   PubMed Web of Science ®Google Scholar
• Rohrer JS, Thayer J, Weitzhandler M, Avdalovic N. Analysis of the N-acetylneuraminic acid and N-glycolylneuraminic acid contents of glycoproteins by high-pH anion-exchange chromatography with pulsed amperometric detection. Glycobiology 1998; 8:35–43; PMID:9451012; http://dx.doi.org/10.1093/glycob/8.1.35
   PubMed Web of Science ®Google Scholar
• Ghaderi D, Taylor RE, Padler-Karavani V, Diaz S, Varki A. Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins. Nat Biotechnol 2010; 28:863–7; PMID:20657583; http://dx.doi.org/10.1038/nbt.1651
   PubMed Web of Science ®Google Scholar
• Higgins E. Carbohydrate analysis throughout the development of a protein therapeutic. Glycoconj J 2010; 27:211–25; PMID:19888650; http://dx.doi.org/10.1007/s10719-009-9261-x
   PubMed Web of Science ®Google Scholar
• Manzi A. Acid hydrolysis for release of monosaccharides. Curr Protoc Mol Biol 2001; 17:17.16.1-17.16.11; Chapter 17:Unit17
   Google Scholar
• Townsend RR, Hardy MR. Analysis of glycoprotein oligosaccharides using high-pH anion exchange chromatography. Glycobiology 1991; 1:139–47; PMID:1823157; http://dx.doi.org/10.1093/glycob/1.2.139
   PubMedGoogle Scholar
• Angeloni S, Ridet JL, Kusy N, Gao H, Crevoisier F, Guinchard S, Kochhar S, Sigrist H, Sprenger N. Glycoprofiling with micro-arrays of glycoconjugates and lectins. Glycobiology 2005; 15:31–41; PMID:15342550; http://dx.doi.org/10.1093/glycob/cwh143
   PubMed Web of Science ®Google Scholar
• Kuno A, Uchiyama N, Koseki-Kuno S, Ebe Y, Takashima S, Yamada M, Hirabayashi J. Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling. Nat Methods 2005; 2:851–6; PMID:16278656; http://dx.doi.org/10.1038/nmeth803
   PubMed Web of Science ®Google Scholar
• Pilobello KT, Krishnamoorthy L, Slawek D, Mahal LK. Development of a lectin microarray for the rapid analysis of protein glycopatterns. Chembiochem 2005; 6:985–9; PMID:15798991; http://dx.doi.org/10.1002/cbic.200400403
   PubMed Web of Science ®Google Scholar
• Zheng T, Peelen D, Smith LM. Lectin arrays for profiling cell surface carbohydrate expression. J Am Chem Soc 2005; 127:9982–3; PMID:16011345; http://dx.doi.org/10.1021/ja0505550
   PubMed Web of Science ®Google Scholar
• Dan X, Liu W, Ng TB. Development and Applications of Lectins as Biological Tools in Biomedical Research. Med Res Rev 2015; PMID:26290041
   PubMed Web of Science ®Google Scholar
• Uchiyama N, Kuno A, Tateno H, Kubo Y, Mizuno M, Noguchi M, Hirabayashi J. Optimization of evanescent-field fluorescence-assisted lectin microarray for high-sensitivity detection of monovalent oligosaccharides and glycoproteins. Proteomics 2008; 8:3042–50; PMID:18615430; http://dx.doi.org/10.1002/pmic.200701114
   PubMed Web of Science ®Google Scholar
• Hirabayashi J, Yamada M, Kuno A, Tateno H. Lectin microarrays: concept, principle and applications. Chem Soc Rev 2013; 42:4443–58; PMID:23443201; http://dx.doi.org/10.1039/c3cs35419a
   PubMed Web of Science ®Google Scholar
• Ebe Y, Kuno A, Uchiyama N, Koseki-Kuno S, Yamada M, Sato T, Narimatsu H, Hirabayashi J. Application of lectin microarray to crude samples: differential glycan profiling of lec mutants. J Biochem 2006; 139:323–7; PMID:16567396; http://dx.doi.org/10.1093/jb/mvj070
   PubMed Web of Science ®Google Scholar
• Tateno H, Uchiyama N, Kuno A, Togayachi A, Sato T, Narimatsu H, Hirabayashi J. A novel strategy for mammalian cell surface glycome profiling using lectin microarray. Glycobiology 2007; 17:1138–46; PMID:17693441; http://dx.doi.org/10.1093/glycob/cwm084
   PubMed Web of Science ®Google Scholar
• Cook MC, Kaldas SJ, Muradia G, Rosu-Myles M, Kunkel JP. Comparison of orthogonal chromatographic and lectin-affinity microarray methods for glycan profiling of a therapeutic monoclonal antibody. J Chromatogr B Analyt Technol Biomed Life Sci 2015; 997:162–78; PMID:26114652; http://dx.doi.org/10.1016/j.jchromb.2015.05.035
   PubMed Web of Science ®Google Scholar
• Ghaderi D, Zhang M, Hurtado-Ziola N, Varki A. Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation. Biotechnol Genet Eng Rev 2012; 28:147–75; PMID:22616486; http://dx.doi.org/10.5661/bger-28-147
   PubMed Web of Science ®Google Scholar